Yuting Tang

1.6k citations
65 papers · 1.1k indexed · h-index 19
Topics
RNA modifications and cancer (16 papers)MicroRNA in disease regulation (13 papers)Cancer-related molecular mechanisms research (13 papers)

In The Last Decade

Yuting Tang

60 papers receiving 1.1k citations

Peers

Yuting Tang
Comparison fields: 5 of 103
  • Molecular Biology 757
  • Cancer Research 336
  • Genetics 148
  • Immunology 111
  • Oncology 103
Replace Praphulla Chandra Shukla with:
Praphulla Chandra Shukla India
Luisa Salvatori Italy
İbrahim Tekedereli Türkiye
Haiyan You China
Sarah Tonack Germany
Liang Shi China
Zherui Wu China
Mei Yu China
Vincent W.S. Liu Hong Kong
Rui Ni China
Yuting Tang relative to Praphulla Chandra Shukla India Praphulla Chandra Shukla's profile →
Citations per field
00.5×2.5×
Praphulla Chandra Shukla · 1×
Citations per year

Countries citing papers authored by Yuting Tang

Since Specialization
Citations

This map shows the geographic impact of Yuting Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Tang more than expected).

Fields of papers citing papers by Yuting Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Tang. The network helps show where Yuting Tang may publish in the future.

Co-authorship network of co-authors of Yuting Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Tang. A scholar is included among the top collaborators of Yuting Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Tang. Yuting Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 3
5 1
6 7
7 13
8 3
9 10
10 18
11 25
12 35
13 7
14 24
15 1
16 8
17 73
18 31
19 46
20 67

About Yuting Tang

Yuting Tang is a scholar working on Cancer Research, Complementary and Manual Therapy and Molecular Biology, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (16 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (13 papers). The work is most often cited by research in Cancer Research (336 citations), Molecular Biology (757 citations) and Reproductive Medicine (67 citations). Yuting Tang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Donald Defranco, Bimei Jiang, Hui Sun, Lubing Zhou, Xiaofang Lin, Yuanbin Li, Pengfei Liang, Xianzhong Xiao, Cheng Chen and Xiaodong Ma. Their work appears in journals such as Molecular and Cellular Biology, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026